A multicenter, double-blind, randomized 2x2 factorial design study to compare the efficacy of early (<6 hours) versus late (24-48 hours) ACE-inhibition and to compare the efficacy of Zofenopril and Lisinopril on oxidative reperfusion injury after a first acute anterior myocardial infarction: the ZAAMIS (Zofenopril After Acute Myocardial Infarction Study).
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Aug 2014
At a glance
- Drugs Zofenopril (Primary) ; Lisinopril
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms ZAAMIS
- Sponsors Menarini
- 07 Apr 2008 New trial record.